Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026)

Elanco Animal Health has disclosed Non-Current Debt across 9 years of filings, most recently posting $3.9 billion for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $3.9 billion, down 9.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 billion (down 9.95% YoY), and the FY2025 annual result was $3.9 billion, down 7.81% from the prior year.
• Non-Current Debt came in at $3.9 billion for Q1 2026 at Elanco Animal Health, down from $3.9 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $6.1 billion in Q1 2022 to a low of $3.9 billion in Q1 2026.
• The 5-year median for Non-Current Debt is $5.5 billion (2024), against an average of $5.1 billion.
• Across the five-year window, Non-Current Debt climbed 9.31% in 2022 and declined 26.52% in 2024, its largest moves.
• Elanco Animal Health's Non-Current Debt stood at $5.4 billion in 2022, then rose by 5.29% to $5.7 billion in 2023, then decreased by 25.44% to $4.3 billion in 2024, then declined by 7.81% to $3.9 billion in 2025, then declined by 0.63% to $3.9 billion in 2026.
• The last three Non-Current Debt figures came in at $3.9 billion (Q1 2026), $3.9 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.